30th Jun 2015 09:33
LONDON (Alliance News) - Deltex Medical Group PLC said Tuesday that a hospital in the northwestern US has opened an account on its platform programme, which means it is committed to purchase at least 30 of the company's probes per month, with the expectations of increasing volumes in the future.
The company makes oesophageal Doppler monitoring technology. The monitoring systems are used to measure blood flow during surgery by generating a low-frequency ultrasound signal and utilising the Doppler effect. The Doppler effect is the change in frequency of a wave for an observer moving relative to its source, such as the way in which the noise of a siren changes when it passes by.
Deltex is deploying an existing local dedicated trainer to support this new account; the company sends trainers into hospitals to train physicians in using its technology.
"This is the fifth account added to our US platform programme this year and the eleventh in total. We are encouraged that, with a procurement framework in place, we were able to progress from initial demonstration through clinical evaluation and into an implementation programme in under three months. We are targeting further hospitals in this system in our drive to get to 30 platform programme accounts by mid-2016," said Chief Executive Ewan Phillips in a statement.
Shares in Deltex Medical are trading up 2.9% at 6.18 pence Tuesday morning.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
Deltex Medical